-
Ashley, SE, Jones, AC, Anderson, D, Holt, PG, Bosco, A, Tang, MLK.
Remission of peanut allergy is associated with rewiring of allergen-driven T helper 2-related gene networks..
Allergy
77(10)
:
3015 -3027
2022
view publication
-
Loke, P, Hsiao, K-C, Lozinsky, AC, Ashley, SE, Lloyd, M, Pitkin, S, Axelrad, CJ, Jayawardana, KS, Tey, D, Su, EL, et al.
Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement..
Clin Exp Allergy
52(6)
:
806 -811
2022
view publication
-
Hsiao, K-C, Ponsonby, A-L, Ashley, S, Lee, CYY, Jindal, L, PPOIT Study Team, Masters of advanced practice nursing, Tang, MLK.
Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy (PPOIT) in children with peanut allergy..
Clin Exp Allergy
2022
view publication
-
Loke, P, Orsini, F, Lozinsky, AC, Gold, M, O'Sullivan, MD, Quinn, P, Lloyd, M, Ashley, SE, Pitkin, S, Axelrad, C, et al.
Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial..
Lancet Child Adolesc Health
6(3)
:
171 -184
2022
view publication
-
Lloyd, M, Loke, P, Ashley, S, Lozinsky, A, Orsini, F, Gold, M, O'Sullivan, M, Prescott, S, Allen, K, Pitkin, S, et al.
Health-related quality of life outcomes in a Phase 2b Randomized Trial evaluating the effectiveness and safety of Probiotic Peanut Oral Immunotherapy.
Journal of Allergy and Clinical Immunology
149(2)
:
ab317
2022
view publication